NasdaqGS - Nasdaq Real Time Price USD
Enanta Pharmaceuticals, Inc. (ENTA)
5.27
+0.09
+(1.74%)
As of 1:11:03 PM EDT. Market Open.
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Cash Flow
-70,577
-78,764
-103,154
-84,782
-69,996
Investing Cash Flow
140,255
58,235
-53,578
54,897
36,991
Financing Cash Flow
-25,262
-27,626
198,126
20,033
3,080
End Cash Position
88,317
41,201
89,356
47,962
57,814
Income Tax Paid Supplemental Data
--
241
4,899
0
32
Interest Paid Supplemental Data
11,575
11,710
1,987
0
--
Capital Expenditure
-25,906
-17,948
-9,058
-2,125
-750
Repayment of Debt
-25,255
-27,479
0
0
--
Free Cash Flow
-96,483
-96,712
-112,212
-86,907
-70,746
9/30/2021 - 3/21/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INVA Innoviva, Inc.
18.43
+2.33%
ACRS Aclaris Therapeutics, Inc.
1.2200
+3.39%
SLRN Acelyrin, Inc.
2.1950
+7.33%
EWTX Edgewise Therapeutics, Inc.
14.40
-1.03%
PSTV Plus Therapeutics, Inc.
0.5037
-4.98%
AKTX Akari Therapeutics, Plc
1.3393
+2.24%
SPRC SciSparc Ltd.
0.3101
-4.02%
CMND Clearmind Medicine Inc.
0.9500
-1.14%
MLYS Mineralys Therapeutics, Inc.
15.26
+0.96%
TYRA Tyra Biosciences, Inc.
9.74
+0.72%